Clobazam

BreastfeedingPediatric
  • TRADE NAMES: Castillium; Frisium (Sanofi-Aventis); Mystan; Odipam; Onfi (Lundbeck); Urbanil; Urbanyl
  • INDICATIONS: Epilepsy adjunct therapy, psychosis
  • CLASS: Antiepileptic, Benzodiazepine
  • HALF-LIFE: 36–42 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Alcohol, Cannabidiol, Carbamazepine, Cenobamate, Cimetidine, Disulfiram, Fluconazole, Fluvoxamine, Hormonal contraceptives, Levodopa, Moxonidine, Omeprazole, Phenytoin, Rifampin, Sodium Oxybate, Stiripentol, Theophylline, Ticlopidine, Valproic Acid

PREGNANCY CATEGORY: C

Our database has 49 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
MUCOSAL.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
NEUROMUSCULAR/SKELETAL.
RESPIRATORY.
OTHER.


Page last updated 08/02/2021

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top